Afuresertib +Sintilimab+Chemotherapy in Patients With Selected Solid Tumors That Resistance to Prior Anti-PD-1/PD-L1
Laekna Limited
Laekna Limited
Merck Sharp & Dohme LLC
NuCana plc
University of Arizona
Dartmouth-Hitchcock Medical Center
Memorial Sloan Kettering Cancer Center